I would rather ask these questions ---
What's the price
I would rather ask these questions ---
What's the price of an antigen test kit 5M UNITS volume per day?
Irrelevant to QMC
What's QMC HealthID's share of the price of an antigen test kit 5M UNITS volume per day?
Probably 0, the Health I.D. is optional use tool in the kit and QMC will get paid by the person if they choose to use the app. Now if there is license fee that QMC gets, then that's great. However, said license fee could be based on time (say per year) not kit. Maybe I am wrong, but that is how I would structure a.deal with QMC if I were Innova.
Ask the same questions about antibody tests.
Same
Ask the same questions about 50M UNITS volume per day.
Irrelevant to QMC
Ask the same questions if QMC also gets revenue from either gold nanocrystals or quantum dots in the assays and anticounterfeiting for the whole deal?
That is the million dollar question and the only one to me that really matters. If we are supplying raw materials to the kit, then bravo for QMC. BUT, if that is the case then why not pr that QMC is building more reactors to meet demands for their nanocrystals? Million ways to craft a pr to get the investment community excited about the possibilities here, most of which would not violate and NDA (if one even exist). Everybody here jumps my case about being negative, but how about we start holding the CEO accountable for not be accountable.
now commence with telling me I am full of crap and how all QMC decisions are amazing.
btw....rememeber when I found out that QMC had joined the KISCO "ecosystem" and we all thought our dots were going to go into the making of all things. KISCO makes millions of dollars.....we were part of their ecosystem....how much revenue did we gain again??? That's right.
The only thing that is making this interesting this time is the dilution slow down and the hires. The Innova news is a sidebar to me at this point, because nobody knows the deal.
Read More: https://investorshangout.com/post/view?id=603...z6ksdR9Bcu
3
Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Top 5 Most Recently Viewed Articles
Weibo's Quarter: A Mixed Bag of Gains and Losses Weibo Corporation, a major player in China’s social media scene, just dropped its Q1 2026 financials. The results painted a familiar picture: some wins, some setbacks. Net revenues hit $421.3 million, a 6% climb compared to last year, but the devil's in the details. With an industry often teetering between opportunity and...
Continue Reading
Jeffs’ Brands Expands Horizons with Strategic Transactions Tel Aviv, Israel - Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW) has recently unveiled two major transactions with public companies, appraising its assets at approximately $23.4 million to $26 million. This marks a pivotal moment in Jeffs’ Brands’ strategy to expand...
Continue Reading
Understanding the Digital Well-being Hub Cisco has partnered with the Organisation for Economic Co-operation and Development (OECD) to launch the Digital Well-being Hub, a significant initiative that aims to study the multifaceted effects of digital technology on individual well-being. This groundbreaking project seeks to provide a comprehensive view of how technology...
Continue Reading
Charles S. Liberis Recognized for Excellence in Law Charles S. Liberis has recently been highlighted as a Pinnacle Professional Member, showcasing his extensive contributions to the field of real estate law. His esteemed title signifies his dedication to providing top-notch legal services, particularly in real estate expertise. The Liberis Law Firm: A Beacon of Legal...
Continue Reading
CR Fitness Holdings Announces New Crunch Facility CR Fitness Holdings LLC., a prominent franchisee of Crunch Fitness, has unveiled exciting plans for a new Crunch Fitness location. The latest facility will embrace a modern approach to fitness, transforming how local residents engage with their health and wellness. Details of the New Crunch Fitness Location This...
Continue Reading